Ovation Science Inc
Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness solutions under the Invibe MD name; anti-aging products and… Read more
Ovation Science Inc (OVATF) - Net Assets
Latest net assets as of September 2025: $-1.42 Million USD
Based on the latest financial reports, Ovation Science Inc (OVATF) has net assets worth $-1.42 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($28.80K) and total liabilities ($1.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.42 Million |
| % of Total Assets | -4926.05% |
| Annual Growth Rate | N/A |
| 5-Year Change | -135.08% |
| 10-Year Change | N/A |
| Growth Volatility | 146.97 |
Ovation Science Inc - Net Assets Trend (2017–2024)
This chart illustrates how Ovation Science Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ovation Science Inc (2017–2024)
The table below shows the annual net assets of Ovation Science Inc from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-1.09 Million | -67.22% |
| 2023-12-31 | $-652.10K | -686.12% |
| 2022-12-31 | $-82.95K | -111.75% |
| 2021-12-31 | $706.15K | -77.28% |
| 2020-12-31 | $3.11 Million | +110.36% |
| 2019-12-31 | $1.48 Million | -32.51% |
| 2018-12-31 | $2.19 Million | +287.23% |
| 2017-12-31 | $565.41K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ovation Science Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 698639600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.52 Million | % |
| Other Comprehensive Income | $1.43 Million | % |
| Total Equity | $-1.09 Million | 100.00% |
Ovation Science Inc Competitors by Market Cap
The table below lists competitors of Ovation Science Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Fanhua Inc.
NASDAQ:AIFU
|
$991.26K |
|
CONSOLIDATED EDISON - Dusseldorf Stock Exchang
DU:EDC
|
$991.36K |
|
ZHENRO PROP.GRP DL-00001
F:1ZZ
|
$993.41K |
|
Hiremii Ltd
AU:HMI
|
$994.30K |
|
Lifeist Wellness Inc.
OTCQB:LFSWF
|
$990.72K |
|
PACCAR (PAE.SG)
STU:PAE
|
$990.03K |
|
Sawang Export Public Company Limited
BK:SAWANG
|
$989.73K |
|
Infield Minerals Corp
V:INFD
|
$989.29K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ovation Science Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -652,104 to -1,090,423, a change of -438,319.
- Net loss of 456,197 reduced equity.
- New share issuances of 67,626 increased equity.
- Other comprehensive income decreased equity by 49,747.
- Other factors decreased equity by 1.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-456.20K | -41.84% |
| Share Issuances | $67.63K | +6.2% |
| Other Comprehensive Income | $-49.75K | -4.56% |
| Other Changes | $-1.00 | -0.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Ovation Science Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.02 | $0.05 | x |
| 2018-12-31 | $0.14 | $0.05 | x |
| 2019-12-31 | $0.06 | $0.05 | x |
| 2020-12-31 | $0.12 | $0.05 | x |
| 2021-12-31 | $0.02 | $0.05 | x |
| 2022-12-31 | $0.00 | $0.05 | x |
| 2023-12-31 | $-0.02 | $0.05 | x |
| 2024-12-31 | $-0.03 | $0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ovation Science Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -402.95%
- • Asset Turnover: 1.77x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-58.47%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -10.88% | -490.56% | 0.01x | 1.59x | $-118.08K |
| 2018 | -23.22% | -527.35% | 0.04x | 1.24x | $-727.35K |
| 2019 | -56.57% | -276.45% | 0.16x | 1.25x | $-983.70K |
| 2020 | -38.12% | -157.98% | 0.23x | 1.05x | $-1.50 Million |
| 2021 | -338.99% | -1064.14% | 0.29x | 1.09x | $-2.46 Million |
| 2022 | 0.00% | -574.76% | 1.32x | 0.00x | $-785.76K |
| 2023 | 0.00% | -1312.93% | 0.81x | 0.00x | $-747.94K |
| 2024 | 0.00% | -402.95% | 1.77x | 0.00x | $-347.15K |
Industry Comparison
This section compares Ovation Science Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ovation Science Inc (OVATF) | $-1.42 Million | -10.88% | N/A | $991.02K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |